Researchers demonstrated that major histocompatibility complex (MHC):T cell antigen receptor signaling could be required to initiate a cancer phenotype from an understudied developmental state that appeared to be represented in the mouse and human disease spectrum.
[Proceedings of the National Academy of Sciences of the United States of America]